Congenital hypothyroidism is one of the most preventable causes of intellectual disability and growth failure in children. Early screening at birth plays a crucial role in detecting thyroid dysfunction before clinical symptoms appear. Prompt diagnosis and timely initiation of thyroxine therapy can ensure normal growth and neurodevelopment. This session highlights the importance of newborn screening programs, diagnostic challenges, and the long-term impact of early intervention on quality of life.
Associate Director, Endocrinology, Regency Health, Uttar Pradesh
Dr. Anurag Bajpai is a distinguished Pediatric and Adolescent Endocrinologist with over 17 years of clinical and academic experience in the field of endocrinology. He currently serves as the Associate Director of Endocrinology at Regency Health, Kanpur, where he has been leading advancements in pediatric endocrine care since October 2022. Dr. Bajpai has been practicing as a Consultant Pediatric and Adolescent Endocrinologist since 2008, with extensive expertise in managing complex endocrine disorders in children and adolescents. He is also the Director of MedEClasses Pvt. Ltd., an innovative online learning initiative offering comprehensive training in Pediatric Endocrinology through interactive videos, case-based learning, and animations. Deeply committed to medical education and professional development, Dr. Bajpai serves as the General Secretary of GROW India and has been instrumental in the GROW Society–MedEClasses Online Pediatric Endocrinology Course, a leading digital platform for endocrine education. His prior international experience includes working as a Pediatric Endocrinologist at the Royal Children’s Hospital, Melbourne, where he honed his clinical and research acumen. With concurrent associations at Fortis Memorial Research Institute, Gurgaon, and Fortis CDOC, New Delhi, Dr. Bajpai continues to contribute significantly to the advancement of pediatric endocrinology in India and beyond.